Microalbuminuria Screening for Detecting Chronic Kidney Disease in the General Population: A Systematic Review

REFERENCES

• Yang WC, Hwang SJ. Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance. Nephrol Dial Transplant. 2008;23:3977–3982.
   PubMed Web of Science ®Google Scholar
• Coresh J, Selvin E, Stevens LA, . Prevalence of chronic kidney disease in the United States. J Am Med Assoc. 2007;298:2038–2047.
   PubMed Web of Science ®Google Scholar
• Wen CP, Cheng TY, Tsai MK, . All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet. 2008;371:2173–2182.
   PubMed Web of Science ®Google Scholar
• Taal MW, Brenner BM. Renal risk scores: progress and prospects. Kidney Int. 2008;73:1216–1219.
   PubMed Web of Science ®Google Scholar
• Levey AS, Atkins R, Coresh J, . Chronic kidney disease as a global public health problem: approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72:247–259.
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–S266.
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49:S12–S154.
   Google Scholar
• American Diabetes Association. Standards of medical care in diabetes – 2012. Diabetes Care. 2012;35(Suppl. 1):S11–S63.
   PubMed Web of Science ®Google Scholar
• Powe NR, Boulware LE. Population-based screening for CKD. Am J Kidney Dis. 2009;53:S64–S70.
   Google Scholar
• Crews DC, Greer RC, Fadrowski JJ, . Setting an agenda for comparative effectiveness systematic reviews in CKD care. BMC Nephrol. 2012;13:74.
   PubMedGoogle Scholar
• Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.
   PubMedGoogle Scholar
• Drummond M, Sculpher M, Torrance G, O’Brien B, Stoddart G. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press; 2005.
   Google Scholar
• Atthobari J, Asselbergs FW, Boersma C, . Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmaco economic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT). Clin Ther. 2006;28:432–444.
   PubMed Web of Science ®Google Scholar
• Hoy WE, Wang Z, Baker PR, Kelly AM. Reduction in natural death and renal failure from a systematic screening and treatment program in an Australian Aboriginal community. Kidney Int. 2003;63(Suppl. 83):S66–S73.
   Google Scholar
• van der Velde M, de Jong PE, Gansevoort RT. Comparison of the yield of different screening approaches to detect chronic kidney disease. Nephrol Dial Transplant. 2010;25:3222–3230.
   PubMedGoogle Scholar
• Gansevoort RT, Verhave JC, Hillege HL, . The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney Int. 2005;67(Suppl. 94):S28–S35.
   Google Scholar
• Jafar TH, Chaturvedi N, Hatcher J, Levey AS. Use of albumin creatinine ratio and urine albumin concentration as a screening test for albuminuria in an Indo-Asian population. Nephrol Dial Transplant. 2007;22:2194–2200.
   PubMed Web of Science ®Google Scholar
• Hoerger TJ, Wittenborn JS, Segel JE, . A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening. Am J Kidney Dis. 2010;55:463–473.
   PubMed Web of Science ®Google Scholar
• Fink HA, Ishani A, Taylor BC, . Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2012;156:570–581.
   PubMed Web of Science ®Google Scholar
• Craig JC, Barratt A, Cumming R, Irwig L, Salkeld G. Feasibility study of the early detection and treatment of renal disease by mass screening. Intern Med J. 2002;32:6–14.
   PubMed Web of Science ®Google Scholar
• Fink HA, Ishani A, Taylor BC, . Chronic Kidney Disease Stages 1–3: Screening, Monitoring, and Treatment. Rockville, MD: Agency for Healthcare Research and Quality; 2012. Report No.: 11(12)-EHC075-EF.
   Google Scholar
• Ewald B, Attia J. Which test to detect microalbuminuria in diabetic patients? A systematic review. Aust Fam Physician. 2004;33:565–567,571.
   Google Scholar